COVID-19 vaccines offer protection against long-term effects, study suggests

A new study in The BMJ explores how far vaccination averted PCC.

Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025 – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 01.10.2024 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

October 2, 2024

Doctor Influenced Gender Care Bans; Cord Blood Banking Scam? Anti-Abortion Extremist

Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. Doctor Drives Gender-Affirming Care Bans Stanley

July 18, 2024

Life sciences deals on track to hit lowest point since 2017

It’s no secret that biotech industry funding has fallen from its Covid highs. But with just a few months left in the year, it’s on

October 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.